BridgeMD
New treatment option for Mediastinum Disease
Official title Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning
ClinicalTrials.gov ID: NCT05792280
What this study is testing
- What it's testing
- The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in mediastinal ultrasound endoscopic scanning. The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- 1\. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography; 3. Agree to participate in this study and sign the informed...
You likely can't join if
- people who meet any of the following criteria cannot be selected for this trial: First. The patient's physical condition does not meet the...
- Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
- Anesthesia assessment failed
- Pregnancy or breastfeeding
- In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
- Recent acute coronary syndrome or clinically unstable ischemic heart attack
See the full eligibility criteria
- 1\. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography; 3. Agree to participate in this study and sign the informed consent form.
- people who meet any of the following criteria cannot be selected for this trial: First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:
- Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
- Anesthesia assessment failed
- Pregnancy or breastfeeding
- In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
- Recent acute coronary syndrome or clinically unstable ischemic heart attack
- Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure\> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory...
- Mediastinal lesions have previously undergone surgery or radiotherapy and chemotherapy;
- Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.